17 BAYCREST | 2024
2022
2023 2024
2021 2019
2020
The Virtual
Behavioural Medicine
program expands our
reach to help dementia
patients and reduce
wait times. Doctors
assess patients
remotely and prescribe
treatments that keep
them at home longer.
Possibilities by
Baycrest, a new,
leading-edge memory
care program for
people with advanced
dementia, ensures they
can live full lives as
much as possible.
Baycrest@Home,
an innovative
program, helps
older adults stay
in their homes
longer and
lends support to
caregivers.
Baycrest Academy
maximizes our
impact with increased
collaboration in
knowledge discovery
and dissemination,
amplifying our reach
and influence.
The Canadian Consortium on
Neurodegeneration in Aging
moves its scientific headquarters
to Baycrest. CCNA, Canada's
largest national dementia
research initiative, brings
together researchers who work
to treat and prevent dementia.
The Bresver
Neuromodulation
& Therapeutics
Program is launched
to investigate
non-invasive
neuromodulation
strategies, as one of
the most promising
treatments for
Alzheimer's disease.
The Anne & Allan Bank Centre
for Clinical Research Trials is
established and positioned at the
forefront of dementia research.
As of 2024, it boasts the largest
number of ongoing therapy and
intervention trials in Canada to
treat and prevent dementia.
Baycrest starts building the
Pamela & Paul Austin AI
Platform to incorporate
artificial intelligence in the
delivery of timely diagnosis
and care for patients with
cognitive difficulties.
